As Louisiana HB 592 moves through legislature, Texas’ workers’ compensation system is again the center of national discussion. Texas Commissioner Ryan Brennan doubled down on advocacy for other states to adopt the Texas-model formulary proclaiming it “a model for the nation” and “the inspiration for many other states’ proposed formularies” citing improvements in return-to-work, medical costs and access to care. Surely, a system as unique as Texas relies on more than a binary list of drugs to accomplish the outcomes documented in its 2016 biennial report. Here is “The Truth Regarding Outcomes in Texas and the Guideline Never Discussed”. Due to reference of the Texas Labor Code, I welcome feedback specifically from the legal community on this piece.
The debate in Louisiana on a drug formulary continues. While HB 592 is being sent to House floor for a vote early next week, HB 529 remains in waiting. Here are my thoughts on why the Texas-model may not produce the expected results in Louisiana.
Is the Agency for Healthcare Research and Quality’s National Guideline Clearinghouse still relevant? Read my latest write-up on this very important subject published in the Louisiana Comp Blog.
Major Overhaul Planned for MTUS The California Department of Industrial Relations Division of Workers’ Compensation (DIR DWC) continues to demonstrate its commitment to improving the quality of medical care available to ill or injured workers in the state by announcing that all MTUS… Read More ›
As discussions about adopting #evidencebasedmedicine guidelines and #drugformularies become more common place throughout the country, it is imperative that the workers’ compensation industry have a good working knowledge of traits present in #trustworthy #EBM – not all guidelines are created equal. Misconceptions exist about the content, and the tools it powers, and who it benefits most. EBM is not primarily for cost containment, it not a license to deny needed care to patients, and it is not one-size-fits all medicine. Let me know your thoughts on how EBM can be better leveraged to improve the quality of care to #injuredworkers.
Today’s workers’ compensation regulatory landscape is populated by requests to standardize the use of prescription drug monitoring technology, evidence-based medicine treatment guidelines, drug formularies, and other modern approaches to Occupational Medicine. All is geared toward minimizing the over-utilization of treatment and… Read More ›